FDA-Approved Menopause Drug Duavee Shows Promise for Breast Cancer Prevention in Phase 2 Trial
A multi-center phase 2 clinical trial led by Northwestern Medicine found that Duavee significantly reduced cell growth in breast tissue among 141 postmenopausal women with ductal carcinoma in situ (DCIS).
USC Spine Center Joins Pivotal CLARITY Trial to Evaluate Nociscan for Chronic Low Back Pain
Keck Medical Center of USC has joined the CLARITY trial to evaluate Aclarion's Nociscan technology, which uses MR Spectroscopy and AI to identify sources of chronic low back pain.
Northwestern Medicine Launches Landmark Study Using Apple Watch to Revolutionize AFib Treatment
Northwestern Medicine researchers are initiating a seven-year clinical trial to determine if wearable technology can reduce continuous blood thinner use in atrial fibrillation patients, potentially decreasing bleeding risks and improving quality of life.
Sibel Health Secures $30 Million Series C Funding and New FDA Clearance for Interoperable Monitoring Platform
Sibel Health has closed a $30 million Series C financing round led by the Steele Foundation for Hope with significant participation from Dräger, positioning the company for commercial expansion.
Northwestern Medicine Selected as First Site for Pivotal CLARITY Trial Testing Nociscan's Low Back Pain Technology
Northwestern Medicine, a leading clinical research institution that conducted over 6,900 studies in 2024, has been selected as the initial site for Aclarion's CLARITY trial investigating Nociscan technology.
COVID-19 Infection Linked to Cancer Regression via Novel Immune Cell Activation
Researchers have discovered that SARS-CoV-2 RNA can trigger the development of inducible nonclassical monocytes (I-NCMs), a unique type of immune cell with anti-cancer properties.
Severe COVID-19 Infection Linked to Cancer Cell Regression in Northwestern Medicine Study
Northwestern Medicine researchers observed cancer regression in some patients who experienced severe COVID-19, suggesting a potential link between the immune response and cancer cell death.
COVID-19 Infection Linked to Cancer Regression in Northwestern Medicine Study
Researchers at Northwestern Medicine have discovered a surprising link between COVID-19 infection and cancer regression, offering potential new avenues for cancer treatment.
Implantable Device Offers Automated Naloxone Delivery for Opioid Overdose Reversal
A novel implantable device, the Naloximeter, has been developed to automatically detect and reverse opioid overdoses by monitoring oxygen levels and delivering naloxone.
NCH Partners with Northwestern Medicine to Expand Cancer Care and Clinical Trial Access in Naples
NCH has partnered with Northwestern Medicine to enhance cancer care in Collier County and broaden access to clinical trials.